If you've decided you want a growth hormone peptide rather than growth hormone itself, you've probably narrowed in on these two names. They show up constantly, often in the same sentence, and they are genuinely similar: both belong to the same family and do the same basic job. The choice between them comes down to one property, and once you understand it, the decision gets a lot clearer.
What CJC-1295 and sermorelin have in common
Both are GHRH analogs. GHRH stands for growth hormone releasing hormone, the natural signal your hypothalamus sends to your pituitary gland telling it to release growth hormone. Sermorelin and CJC-1295 are both lab-made molecules that imitate that signal. Neither contains any growth hormone of its own. Instead, each one prompts your own pituitary to produce more, which means both work within your body's natural feedback system rather than overriding it.
How sermorelin works
Sermorelin is a shortened copy of natural GHRH, containing the first 29 amino acids that carry the active signal. When injected, it binds to the GHRH receptor on your pituitary and triggers a release of growth hormone. Its defining trait is that it's short-acting: it does its job and clears the body within minutes. That brief action closely mirrors the natural pulse of GHRH your body produces, which is part of why sermorelin has the longest and most established track record of this group. It was once an FDA-approved medication used in growth assessment before being withdrawn from the market for commercial reasons, not safety ones.
How CJC-1295 works
CJC-1295 is also a GHRH analog, built on the same active fragment, but it was engineered to last much longer. The version most people mean when they say "CJC-1295" without qualification is modified GRF (1-29), sometimes called CJC-1295 without DAC, which still clears in well under an hour. A second version, CJC-1295 with DAC (drug affinity complex), adds a chemical handle that binds to a blood protein called albumin and keeps the molecule circulating for several days. That difference is large, so it's worth knowing which version a product actually is. The longer it lasts, the longer your pituitary keeps receiving the "release" signal.
Key differences
The headline difference is duration, and it cascades into everything else. Sermorelin acts in a quick burst that fades fast. CJC-1295 without DAC lasts somewhat longer, and CJC-1295 with DAC lasts for days. That single property shapes dosing convenience, how the effect feels, and how closely each one tracks your natural biology.
Because sermorelin clears so quickly, its effect on growth hormone is a brief spike that closely resembles a natural pulse. Your body releases growth hormone in pulses, mostly during deep sleep, and many people consider sermorelin's burst-and-fade pattern the most physiologically natural of the group. The trade-off is timing sensitivity: a short-acting peptide generally has to be taken at the right moment, often at bedtime, to line up with your own rhythm.
CJC-1295 with DAC takes the opposite approach. By keeping GHRH signaling elevated for days, it produces what researchers describe as a sustained increase in baseline growth hormone and IGF-1 (insulin-like growth factor 1, the downstream hormone that does much of the work) rather than a series of clean pulses. The convenience is obvious: far fewer injections. The open question is whether a continuous signal is as desirable as a pulsatile one, since the body's natural design is pulses, not a plateau. This is exactly why CJC-1295 with DAC is so often paired with a separate short-acting peptide to restore some of that pulse character.
Track record and predictability round out the picture. Sermorelin has decades of clinical familiarity behind it, including its history as an approved drug. CJC-1295, particularly the DAC version, is a newer engineered molecule with less long-term human data. Both are sold today as research compounds and are not approved for human use.
| Sermorelin | CJC-1295 | |
|---|---|---|
| Family | GHRH analog | GHRH analog |
| Duration of action | Minutes | Under an hour (no DAC); days (with DAC) |
| GH release pattern | Natural-style pulse | Sustained signal (DAC) |
| Dosing frequency | Daily, timed | Daily to once or twice weekly (DAC) |
| Clinical track record | Long, formerly approved | Newer, less data |
| Best for | Natural rhythm, established history | Convenience, fewer injections |
Bottom line
Sermorelin tends to suit people who want the most natural-feeling, best-established option and don't mind a daily, well-timed injection. Its burst-and-fade action mimics your body's own GHRH pulse, and its long clinical history gives it a familiarity that none of the newer peptides can claim. If your priority is staying close to natural biology with the most track record behind you, this is the conservative choice.
CJC-1295 appeals to people who prioritize convenience and a steadier baseline. The DAC version in particular trades injection frequency for a more continuous signal, which many find easier to sustain over time. Just be clear on which version you're buying, because "with DAC" and "without DAC" behave very differently, and the longer-acting one can't be eased off quickly once it's in your system.
Where to go from here
The DAC question deserves its own look, since it's the single most confused point in this corner of the peptide world. It's broken down in CJC-1295 with DAC vs. Without DAC. If you're still deciding between peptide families altogether, Ipamorelin vs. Sermorelin compares a GHRH analog against a secretagogue, and the broader framework of stimulating versus replacing growth hormone is covered in HGH vs. GH Peptides. To compare pricing across vendors, the Peptide Price Lab tool tracks per-milligram costs in one place.